How Leading Elevator Companies Respond When the Power Goes Out
When the power went out around noon on April 28, Otis mechanic Julio César was conducting an inspection in a Madrid office building. The generator turned on, and he continued working. He thought it was a local issue.
Then the building's maintenance manager informed him of the magnitude of the event: All power, and nearly all cellphone service, was out across Spain and Portugal. They didn't know it at the time, but the outage would last about 10 hours – and up to 16 hours in some areas.
Julio César immediately completed his inspection and went to check the other units on his route to make sure no one was trapped. He prioritized nursing homes and the smaller buildings that he knew did not have backup generators.
'I went to the places first where I knew there might be more vulnerable people,' he said.
Julio César is just one of hundreds of Otis field colleagues in Spain and Portugal who rallied to support people stranded in elevators when the power went out – and later, when power was restored, worked to get elevators back up and running.
Their response was immediate and thorough: In the hours following the historic outage, mechanics worked with public authorities to visit every unit on their routes to ensure there were no entrapments, and rescuing people who were. OTISLINE customer service teams provided immediate support to those who were connected. Then, when power was restored, they set to work getting all elevators back up and running.
Consider these figures:
Spain has the most elevators per resident in the European Union, with almost 1.3 million elevators total, according to the Spanish Elevator Federation. They estimate that 10,000 entrapped passengers were freed on April 28.
Here's what happens at Otis when the power goes out:
Going above their normal call to help others
Otis mechanics freed people trapped in elevators that were not their responsibility – elevators that are not part of the Otis service portfolio. Xavier, an Otis salesman who used to be a mechanic, freed two women in their 90s in the minutes after the blackout started.
One mechanic walked more than 17 kilometers (10.5 miles) to help as many trapped passengers as possible.
Colleagues who were not scheduled to work went to the offices to see how they could help. Those who were working voluntarily worked another shift when transit issues meant some second-shift workers didn't make it into the office or call center.
Mechanics accompanied firefighters to perform rescues. Some Otis colleagues took people with mobility issues into their homes.
When the power came back
By April 29, once entrapments were addressed and power was restored, Otis experts turned quickly to making sure all Otis units were back online and working.
This too required a round-the-clock response from field colleagues.
Some mechanics had accumulated more than 25 calls by 9 a.m. Service was again augmented by extending shifts, and tapping people on their scheduled day off who showed up at the call centers, aware of the workload.
It wasn't until late on April 30 that the crisis was over. Otis had zero calls on hold.
'Through their actions and professionalism, our colleagues in Spain and Portugal exemplified the core values of our company and demonstrated how to put our mission into action,' said Enrique Miñarro Viseras, President of Europe, Middle East, Africa and Latin America. 'Thank you for your resilience, teamwork and unwavering focus on our customers and passengers. Your skills were in high demand and your empathy was evident as you navigated complex situations, provided reassurances and supported everyone affected. We are so proud of all you have done.'
Preparing for next time
In Spain and Portugal, the power outage lasted approximately 10 hours and up to 16 hours in some locations.
Nuno Correia, a field supervisor in Portugal with 35 years of Otis experience, said he had never experienced anything like this. 'I only remember a two-hour power outage in Lisbon 20 years ago, but never a time when communications were down,' Correia said. After the initial nervousness of trying to restore communications, his technicians prioritized helping the factories they service, which were operating at full capacity at the time of the blackout.
While Otis has crisis preparedness plans in place for events like this, each one provides opportunities to learn and improve for the next time, with a focus on the Otis value of safety, and dedication to Otis' mission to be a world-class, customer-centric, service-oriented company.
What to do if you're stuck in an elevator
Importantly, when an elevator stops working, because of a power cut or other reason, passengers are safe inside of the elevator cabin. If communications systems are working, they will have access to an emergency call center. However, if the telecommunications network fails before the signal is activated, passengers must wait in the cabin until an emergency release system is activated, power is restored, or a technician arrives to rescue them.
Some elevators are equipped with an emergency lighting system designed to last at least 1 hour. This emergency lighting is activated automatically as soon as the power supply fails. Depending upon local regulations, elevators may also have an external alarm bell, designed to alert building occupants of an entrapment.
In some countries, Otis businesses are certified to the ISO 22301 standard, which assesses the quality of a company's processes for providing emergency assistance in the event of a blackout.
In addition, post-blackout, Otis has received numerous calls from customers inquiring about products designed to reduce the risk of entrapments in a power cut, including a battery-powered emergency release system, and elevators capable of running on battery and solar power in the event of a power disruption. These Gen2 Switch elevators are currently available in Spain and Portugal. Customers with them reported gratitude that they mitigated the effects of the power outage on their buildings.
About Otis
Otis is the world's leading elevator and escalator manufacturing, installation and service company. We move 2.4 billion people a day and maintain approximately 2.4 million customer units worldwide, the industry's largest Service portfolio. Headquarters in Connecticut, USA, Otis is 72,000 people strong, including 44,000 field professionals, all committed to manufacturing, installing and maintaining products to meet the diverse needs of our customers and passengers in more than 200 countries and territories worldwide. For more information, visit www.otis.com and follow us on LinkedIn, Instagram and Facebook @OtisElevatorCo.
Visit 3BL Media to see more multimedia and stories from Otis Worldwide Corporation
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Vogue
5 hours ago
- Vogue
How I Went From Washing My Hair Daily to Twice a Week
This is not just another article about hair washing. No, it's a true story—one that follows the remarkable journey of how I went from washing my hair every day to twice weekly—no style dramas or greasy strands involved. I'm being a little melodramatic, sure. But I think we can all agree that figuring out the right cadence for shampooing sometimes feels like an epic adventure. My own adventures in hair-washing have been chaotic: I used to wash with just one shampoo each day, then I experimented with double washing and triple-washing. Then I started to space out the washes a bit more. I even briefly tried the no- shampoo thing. Most of the time, I didn't see a big difference—I usually liked my hair as often on the second day as I did on the first. But my personal shampoo epiphany came when I started practicing what I now call 'the Swedish technique.' If you Google it, you won't find it. I'm pretty sure I made the term up. Still, it has merit: The technique consists of washing the scalp—not the hair—using the basic movements of the classic Swedish massage technique. These circular movements are carried out with the fingertips to stimulate blood circulation and release tension. But the key to this modus operandi is not only in the movements, but in the fact that they are done on the scalp using the fingers to apply shampoo to the skin of the head instead of to the hair root. This was explained to me by Felix Burillo, stylist at Espacio Q in Madrid, while he was washing my hair during my latest appointment. He insisted that the fingertips should not rub the hair but the scalp. Why is it important to wash the scalp? Washing the hair correctly does not consist of rubbing the roots, middle, and ends with shampoo, but of washing the scalp and letting the foam fall through the hair to do the rest. The efforts when depositing the shampoo and directing the fingers should be on the skin of the head. 'It is essential to pay attention to the care of the scalp as well as the hair,' says Burillo. 'Keep in mind that the scalp secretes sebum and accumulates dirt caused by product residue and dead skin cells. It is important to clean the scalp and to do it with circular movements that allow us to lift the impurities and clean all the zones well. These movements help to better distribute the natural sebum generated by the scalp,' he says. Time matters When implementing this technique, Burillo insists on using the fingertips, massaging gently, and dedicating time for the massage—around one to two minutes. Washing your hair as a formality and without intention is not a good idea. I can attest that since I have been using this strategy and dedicating more minutes to this technique, my hair stays cleaner longer. 'We have to avoid abrupt or linear movements, since doing so will not stimulate well or clean properly,' says Burillo.
Medscape
6 hours ago
- Medscape
New Hyperkalemia Risk Model for CKD and Diabetes
A new risk model may help identify which patients with chronic kidney disease (CKD) and diabetes are more likely to develop hyperkalemia, granting physicians more confidence in prescribing medications like finerenone. However, researchers caution that further validation is needed. The model is based on pooled data from two phase 3 trials of finerenone: FIDELIO-DKD (Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease) and FIGARO-DKD (Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease). The combined dataset, known as FIDELITY, includes 6355 patients in the placebo groups. Researchers used this dataset to develop the risk score, identifying seven factors independently associated with the primary outcome of new onset of hyperkalemia (incident serum potassium level > 5.5 mmol/L): Serum potassium > 4.5 mmol/L Prior history of hyperkalemia No use of sodium-glucose co-transporter 2 inhibitor Urine albumin-to-creatinine ratio > 1000 mg/g Hemoglobin < 12 g/dL No use of thiazide-type diuretics Estimated glomerular filtration rate < 45 mL/min/1.73 m2 The model was subsequently validated using data from the finerenone groups in FIDELITY. In their paper, published online in the European Heart Journal , João Pedro Ferreira, MD, PhD, of the Cardiovascular Research and Development Center at the University of Porto, Porto, Portugal, and coauthors noted that the model could be used to reduce the risk for hyperkalemia among high-risk patients receiving finerenone. 'This could include tailoring of individualized treatment and follow-up strategies (eg, frequency of visits and serum potassium assessments, and use of potassium binders), thus optimizing patient management and potentially improving outcomes,' they noted. Welcome Results, Validation Required CKD, which affects more than 800 million people worldwide, is a common complication of diabetes. An estimated 15%-40% of people with CKD in the setting of diabetes may have hyperkalemia, noted Bernard G. Jaar, MD, MPH, clinical director for Nephrology at Johns Hopkins School of Medicine, Baltimore, who was not involved in the study. In an email exchange with Medscape Medical News , Jaar described the study as 'welcome and much needed.' He noted that hyperkalemia poses a challenge for clinicians, as many medications required for optimal care in CKD — including renin-angiotensin-aldosterone system (RAAS) blockade agents and finerenone — can raise serum potassium. 'This is a true barrier to care,' Jaar wrote. 'Clinicians are worried about the potential complications associated with hyperkalemia, such as arrhythmias and even death.' Jaar noted that the FIDELITY analysis has several strengths, including its large sample size of patients with varying stages of CKD and degrees of proteinuria, and a risk score model that incorporated readily available clinical variables. He added that it reports a stepwise increase in hyperkalemia risk across risk score tertiles in both placebo and finerenone groups, even though all patients were already on a maximally tolerated RAAS blockade agent. However, he questioned the study's generalizability, given that it excluded patients if their serum potassium was > 4.8 mmol/L. 'This risk model in predicting hyperkalemia needs to be validated in other populations where diet may be different,' Jaar wrote. 'Also, this needs to be validated in at-risk populations during real-life experience and not only in patients enrolled in clinical trials, who are typically highly motivated and selected.' Future Applications Rajiv Agarwal, MD, MS, professor emeritus of medicine at Indiana University and a lead researcher in the finerenone clinical studies, echoed the need for further validation of this tool. Although not involved with the development of the risk model, Agarwal was an author on key publications from the FIGARO-DKD, FIDELIO-DKD, and FIDELITY studies. Agarwal suggested that this model's approach could be applied to other therapies, including aldosterone synthase inhibitors in a similar population with CKD. He also noted the importance of incorporating validated risk models for hyperkalemia into electronic medical records or apps, particularly in countries with limited access to care, like China and India. This would allow more nuanced approaches for following up patients taking drugs with established hyperkalemia risk. 'If the patient cannot come after a month, can I make a clinical judgment and say, 'Okay, if you came back after 3 months, your risk of hyperkalemia is low enough that I'm willing to take that risk,'' he said. 'Or if the risk of hyperkalemia is high, you can tell the patient who can't come back in 30 days, 'I don't think I want to prescribe this drug for you'.' The work on the risk model was supported by Bayer, which also funded the FIDELIO-DKD and FIGARO-DKD studies and pooled analysis. The study's authors included Bayer employees. Other financial relationships of the authors included research support, consulting and other fees from companies including: Abbott Vascular, Amgen, Astellas, AstraZeneca, Bayer, BioVentrix, Boehringer Ingelheim, Brahms, Brainstorm Medical, Cardiac Dimensions, Cardior, Cereno Scientific, CSL Vifor, CVRx, Edwards, Eli Lilly, G3 Pharmaceuticals, Gilead, GSK, Impulse Dynamics, Janssen, KBP Biosciences, Mundipharma, Novartis, Novo Nordisk, Occlutech, PhaseBio, Proton Intel, Respicardia, Sanofi, Sarfez, scPharmaceuticals, Servier, SQ Innovation, Tricida, Vectorious, Vifor International, and V-Wave. Agarwal had received support from Bayer. He also had received consulting fees and other support from Boehringer Ingelheim, Novartis, Akebia, Intercept Pharma, Alnylam, and Vertex. Jaar reported no relevant financial disclosures.
Forbes
7 hours ago
- Forbes
Real Madrid Shortlists This Striker As Latest Signing
Real Madrid is interested in signing a veteran striker and has already shortlisted a La Liga star in that respect according to Mundo Deportivo, which cited anonymous sources. Because of newfound domestic dominance from bitter rival FC Barcelona, and being outclassed by Arsenal on the continent in the Champions League quarterfinals, Madrid finished this season without major silverware. Its 2023/2024 campaign under the since departed Carlo Ancelotti was a different story, however, with Los Blancos enjoying a European Cup, La Liga and Super Cup treble. One of the unexpected heroes of that immortal campaign of course, however, was Joselu. Coming off the bench to sink Bayern Munich in a dramatic UCL semifinal second leg at the Bernabeu, he then fled to Qatar for what should be one last big career day in his mid-30s. Though Kylian Mbappe did a fine job in a new role as a central number 9, winning Europe's Golden Boot in the process, perhaps one of the reasons for coming up short last time round was the lack of a veteran marksman who could come off the bench and score a much-needed goal. Under Xabi Alonso in 2025/2026, Madrid seeks to provide the legendary midfielder with such an option by pursuing Ante Budimir according to Mundo Deportivo. Scoring 24 goals and providing four assists as Osasuna finished ninth and only just missed out on European qualification to Rayo Vallecano, Budimir turns 34 on July 22 and can be picked up for a cut fee. That's around $9 million (€8 million) if his next stop is elsewhere in Spain, with another couple of million euros slapped on to the price if a potential suitor is located elsewhere. If Budimir could be bought and scores the important goals to land titles like Joselu did, his transfer would pretty much end up paying for itself. Though Kylian Mbappe will likely remain Xabi Alonso's first choice for the striker's position, bringing in Budimir would obviously give the ex-Leverkusen tactician further options up front. Essentially, the potential new acquisition would battle for leftover minutes with Endrick, who enjoyed little prominence on Ancelotti's watch at Real Madrid but could now be reunited with him on international duty for Brazil.
